Showing 141 - 160 results of 622 for search '"Neuropsychopharmacology"', query time: 0.08s Refine Results
  1. 141
    A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch

    A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch by Minako Hagikura, Toshiya Inada

    Published 2023-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  2. 142
    High‐dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital

    High‐dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital... by Yuji Yamada, Yuma Yokoi, Zui Narita, Naotsugu Hirabayashi

    Published 2020-12-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  3. 143
    A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination

    A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination by Tomoyuki Imai, Sho Ochiai, Takehiro Ishimaru, Hayato Daitoku, Yusuke Miyagawa, Ryuji Fukuhara, Shuken Boku, Minoru Takebayashi

    Published 2022-06-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  4. 144
    Effects of high‐fat diet on nutrient metabolism and cognitive functions in young APPKINL‐G‐F/NL‐G‐F mice

    Effects of high‐fat diet on nutrient metabolism and cognitive functions in young APPKINL‐G‐F/NL‐G‐F mice by Wei Wang, Daisuke Tanokashira, Yudai Shibayama, Ryuhei Tsuji, Megumi Maruyama, Chiemi Kuroiwa, Takashi Saito, Takaomi C. Saido, Akiko Taguchi

    Published 2022-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  5. 145
    Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia

    Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia by Momoka Yamada, Norio Sugawara, Yasushi Kawamata, Norio Yasui‐Furukori

    Published 2023-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  6. 146
    Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole

    Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole by Tetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, Tsuyoshi Hirose, Takashi Futamura, Robert D. McQuade

    Published 2021-06-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  7. 147
    Detecting early symptoms of mental health deterioration using handwriting duration parameters

    Detecting early symptoms of mental health deterioration using handwriting duration parameters by Yuhei Mashio, Hideo Kawaguchi

    Published 2020-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  8. 148
    Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study

    Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study by Philip D. Harvey, Hiroshi Nakamura, Sadanori Miura

    Published 2020-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  9. 149
    Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice

    Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice by Naoki Amada, Tsuyoshi Hirose, Mikio Suzuki, Yusuke Kakumoto, Takashi Futamura, Kenji Maeda, Tetsuro Kikuchi

    Published 2023-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  10. 150
    Quantification of cytosine modifications in the aged mouse brain

    Quantification of cytosine modifications in the aged mouse brain by Hiroko Sugawara, Akitoshi Date, Satoshi Fuke, Yutaka Nakachi, Tadafumi Kato, Minoru Narita, Miki Bundo, Kazuya Iwamoto

    Published 2024-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  11. 151
    Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan

    Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan by Kenji Miki, Aya Nakae, Kenrin Shi, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Manabu Ikeda, Masahiko Shibata, Masao Yukioka, Ryota Hashimoto

    Published 2018-12-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  12. 152
    Longitudinal characteristics of insight and clinical factors in patients with schizophrenia

    Longitudinal characteristics of insight and clinical factors in patients with schizophrenia by Yoshie Sakai, Satsuki Ito, Junya Matsumoto, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Naomi Hasegawa, Keiichiro Ishimaru, Kenichiro Miura, Ryota Hashimoto

    Published 2023-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  13. 153
    Association study of a single nucleotide polymorphism in the hypoxia response element of the macrophage migration inhibitory factor gene promoter with suicide completers in the Japanese population

    Association study of a single nucleotide polymorphism in the hypoxia response element of the macrophage migration inhibitory factor gene promoter with suicide completers in the Jap... by Toshiyuki Shirai, Satoshi Okazaki, Takaki Tanifuji, Ikuo Otsuka, Masao Miyachi, Shohei Okada, Ryota Shindo, Tadasu Horai, Kentaro Mouri, Motonori Takahashi, Takeshi Kondo, Yasuhiro Ueno, Akitoyo Hishimoto

    Published 2024-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  14. 154
    Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder

    Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder by Soichiro Ide, Yuiko Ikekubo, Jennifer Hua, Yukio Takamatsu, George R. Uhl, Ichiro Sora, Kazutaka Ikeda

    Published 2018-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  15. 155
    Development of the Japanese version of the Ego‐Dissolution Inventory (EDI)

    Development of the Japanese version of the Ego‐Dissolution Inventory (EDI) by Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M. Nour, Robin Carhart‐Harris, Hiroyuki Uchida

    Published 2024-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  16. 156
    A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation

    A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation by Hazuki Komahashi‐Sasaki, Norio Yasui‐Furukori, Ryo Maehara, Chie Hasegawa, Kazutaka Shimoda

    Published 2022-09-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  17. 157
    DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers

    DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers by Naotaka Izuo, Hajime Miyanishi, Daisuke Nishizawa, Takuma Fujii, Junko Hasegawa, Naomi Sato, Fumihiko Tanioka, Haruhiko Sugimura, Kazutaka Ikeda, Atsumi Nitta

    Published 2023-12-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  18. 158
    Determination of lamotrigine in human plasma using liquid chromatography‐tandem mass spectrometry

    Determination of lamotrigine in human plasma using liquid chromatography‐tandem mass spectrometry by Shogo Itabashi, Rina Bito, Maika Nishina, Maki Fukumoto, Midori Soda, Mitsunori Doi, Shigeyuki Usui, Kiyoyuki Kitaichi

    Published 2019-03-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  19. 159
    PET technology for drug development in psychiatry

    PET technology for drug development in psychiatry by Ryosuke Arakawa, Akihiro Takano, Christer Halldin

    Published 2020-06-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article
  20. 160
    Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome

    Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome by Tomihiko Uemura, Masahiko Mochida, Tatsunaru Matsumi, Katsuhiko Yoshimoto, Yoshitaka Tatebayashi

    Published 2019-12-01
    “…Neuropsychopharmacology Reports…”
    Get full text
    Article

Search Tools: